The results demonstrated that CD133+ glioblastoma cells derived from Han Chinese glioma specimens were more prone to primitive cell differentiation and more invasive than CD133− glioblastoma cells, leading to increased tumor malignancy compared with CD133− cells. The gene discussed is PROM1; the disease is central nervous system cancer.